Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: We recently reported that depressed and anxious primary care patients randomized to a moderated Internet support group (ISG) plus computerized cognitive behavioral therapy (CCBT) did not experience improvements in depression and anxiety over CCBT alone at 6-month follow-up. Objective: The “1% Rule” posits that 1% of participants in online communities generate ~90% of new user-created content. The aims of this study were to apply the 1% Rule to categorize patient engagement with the ISG and identify whether any patient subgroups benefitted from ISG use. Methods: We categorized the 302 patients randomized to the ISG as: superusers (1%, N=3), top contributors (10%, N=30), contributors (36%, N=108), observers (29%, N=87) and those who never logged-in (24%, N=74). We then applied linear mixed models to examine associations between engagement and 6-month changes in health-related quality of life (HRQoL; SF-12 MCS) and depression and anxiety symptoms (PROMIS). Results: At baseline, participants’ mean age was 42.6 years, 81% were female, and mean PHQ-9, GAD-7 and SF-12 MCS scores were 13.4, 12.6 and 31.7, respectively. Of the 76% who logged-in, 62% created ≥1 post (median: 1 [IQR 0,5]); superusers created 40% of posts (median: 246 [IQR 78,306]), top contributors created 38% (median: 11 [IQR 10,18]), and contributors created 22% (median: 3 [IQR 1,5]). Compared to participants who never logged-in, the combined superuser + top contributor subgroup (N=33) reported 6-month improvements in anxiety (PROMIS: -11.6 vs. -7.8; p=.04) and HRQoL (SF-12 MCS: 16.1 vs. 10.1; p=.01) but not in depression. No other subgroup reported significant symptom improvements. Conclusions: Patient engagement with the ISG was more broadly distributed than predicted by the 1% Rule. The 11% of participants with the highest engagement levels reported significant improvements in anxiety and HRQoL. Clinical Trial: ClinicalTrials.gov NCT01482806